AU2002213450A1 - Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof - Google Patents
Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereofInfo
- Publication number
- AU2002213450A1 AU2002213450A1 AU2002213450A AU1345002A AU2002213450A1 AU 2002213450 A1 AU2002213450 A1 AU 2002213450A1 AU 2002213450 A AU2002213450 A AU 2002213450A AU 1345002 A AU1345002 A AU 1345002A AU 2002213450 A1 AU2002213450 A1 AU 2002213450A1
- Authority
- AU
- Australia
- Prior art keywords
- human drug
- metabolizing proteins
- nucleic acid
- acid molecules
- molecules encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004169 proteins and genes Human genes 0.000 title 2
- 108090000623 proteins and genes Proteins 0.000 title 2
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24174500P | 2000-10-20 | 2000-10-20 | |
US60/241,745 | 2000-10-20 | ||
US73945600A | 2000-12-19 | 2000-12-19 | |
US09/739,456 | 2000-12-19 | ||
US81864701A | 2001-03-28 | 2001-03-28 | |
US09/818,647 | 2001-03-28 | ||
US09/852,067 US6531297B2 (en) | 2000-10-20 | 2001-05-10 | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
US09/852,067 | 2001-05-10 | ||
PCT/US2001/042528 WO2002034922A2 (en) | 2000-10-20 | 2001-10-05 | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002213450A1 true AU2002213450A1 (en) | 2002-05-06 |
Family
ID=27500053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002213450A Abandoned AU2002213450A1 (en) | 2000-10-20 | 2001-10-05 | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
Country Status (6)
Country | Link |
---|---|
US (1) | US6531297B2 (en) |
EP (1) | EP1358334A2 (en) |
JP (1) | JP2004531207A (en) |
AU (1) | AU2002213450A1 (en) |
CA (1) | CA2426465A1 (en) |
WO (1) | WO2002034922A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020137890A1 (en) * | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
EP1546162B1 (en) | 2002-09-20 | 2011-06-22 | Promega Corporation | Luminescence-based methods and probes for measuring cytochrome p450 activity |
CA2658334C (en) | 2003-01-16 | 2012-07-10 | Caprotec Bioanalytics Gmbh | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
EP2272973B1 (en) * | 2005-05-31 | 2015-05-27 | Promega Corporation | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions |
KR100822818B1 (en) | 2006-09-28 | 2008-04-18 | 삼성전자주식회사 | Block time domain equalizer for time reversal-space time block code system and method for encoding and equalizing received signal in the block time domain equalizer |
EP2323996B1 (en) * | 2008-08-18 | 2014-10-22 | Promega Corporation | Luminogenic compounds and methods to detect cytochrome p450 3a enzymes |
JP6703484B2 (en) | 2014-01-29 | 2020-06-03 | プロメガ コーポレイションPromega Corporation | Quinone-masked probe as a labeling reagent for cellular uptake measurements |
WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5912120A (en) * | 1992-04-09 | 1999-06-15 | The United States Of America As Represented By The Department Of Health And Human Services, | Cloning, expression and diagnosis of human cytochrome P450 2C19: the principal determinant of s-mephenytoin metabolism |
JP2004522404A (en) * | 1999-12-01 | 2004-07-29 | ジェネンテック・インコーポレーテッド | Secreted and transmembrane polypeptides and nucleic acids encoding them |
AU2001227900A1 (en) * | 2000-01-14 | 2001-07-24 | Incyte Genomics, Inc. | Drug metabolizing enzymes |
WO2001055309A2 (en) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
ES2484966T3 (en) * | 2000-04-12 | 2014-08-12 | Novozymes Biopharma Dk A/S | Albumin fusion proteins |
EP1317471A4 (en) * | 2000-08-18 | 2004-07-21 | Human Genome Sciences Inc | 21 human secreted proteins |
-
2001
- 2001-05-10 US US09/852,067 patent/US6531297B2/en not_active Expired - Fee Related
- 2001-10-05 EP EP01981833A patent/EP1358334A2/en not_active Withdrawn
- 2001-10-05 WO PCT/US2001/042528 patent/WO2002034922A2/en not_active Application Discontinuation
- 2001-10-05 AU AU2002213450A patent/AU2002213450A1/en not_active Abandoned
- 2001-10-05 CA CA002426465A patent/CA2426465A1/en not_active Abandoned
- 2001-10-05 JP JP2002537892A patent/JP2004531207A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20020076777A1 (en) | 2002-06-20 |
WO2002034922A3 (en) | 2003-08-28 |
CA2426465A1 (en) | 2002-05-02 |
JP2004531207A (en) | 2004-10-14 |
WO2002034922A2 (en) | 2002-05-02 |
US6531297B2 (en) | 2003-03-11 |
EP1358334A2 (en) | 2003-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001250999A1 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
AU2002214542A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
AU2002213450A1 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
AU2002239256A1 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
AU2002239444A1 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
AU2001265213A1 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
EP1379629A4 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
AU2001288363A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
AU2002229060A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
AU2001271276A1 (en) | Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof | |
AU2002234023A1 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
AU2001257287A1 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
AU2002232452A1 (en) | Human transporter proteins, nucleic acid molecules encoding them,and uses thereof | |
AU2001263401A1 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
AU2002223183A1 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
AU2001289134A1 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
AU2001288688A1 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
AU2001292687A1 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
AU2001292647A1 (en) | Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof | |
AU2001292769A1 (en) | Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof | |
AU2002245128A1 (en) | Human transporter proteins, nucleic acid molecules encoding them, and uses thereof | |
EP1383788A4 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
AU2001264969A1 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
AU2002227336A1 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
AU2002230711A1 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |